Andrographolide targets EGFR to impede epithelial–mesenchymal transition in human breast cancer cells

Simple item page
dc.contributor.authorChutima Kaewpiboon
dc.contributor.authorNawong Boonnak
dc.contributor.authorAbdul-Wahab Salae
dc.contributor.authorSirichatnach Pakdeepromma
dc.contributor.authorNatpaphan Yawut
dc.contributor.authorYoung‐Hwa Chung
dc.date.accessioned2026-05-08T19:16:51Z
dc.date.issued2024-6-5
dc.identifier.doi10.1016/j.jpba.2024.116267
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/15707
dc.publisherJournal of Pharmaceutical and Biomedical Analysis
dc.subjectAndrographolide Research and Applications
dc.subjectPARP inhibition in cancer therapy
dc.subjectBerberine and alkaloids research
dc.titleAndrographolide targets EGFR to impede epithelial–mesenchymal transition in human breast cancer cells
dc.typeArticle

Files

Collections

All